Home Cart Sign in  
Chemical Structure| 164650-44-6 Chemical Structure| 164650-44-6

Structure of Efinaconazole
CAS No.: 164650-44-6

Chemical Structure| 164650-44-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Efinaconazole is a triazole antifungal used to treat for onychomycosis, as it is a 14 alpha-demethylase inhibitor.

Synonyms: KP-103

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Efinaconazole

CAS No. :164650-44-6
Formula : C18H22F2N4O
M.W : 348.39
SMILES Code : C[C@@H](N1CCC(CC1)=C)[C@@](O)(C2=CC=C(F)C=C2F)CN3N=CN=C3
Synonyms :
KP-103
MDL No. :MFCD00936407
InChI Key :NFEZZTICAUWDHU-RDTXWAMCSA-N
Pubchem ID :489181

Safety of Efinaconazole

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H361
Precautionary Statements:P201-P202-P280-P308+P313-P405-P501

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Candida albicans 0.002 mg/ml 24 hours Evaluate the in vitro antifungal activity of KP-103 against Candida albicans, showing that KP-103 was the most active among all tested drugs. PMC90494
Malassezia furfur 0.025 mg/ml 5 days Evaluate the in vitro antifungal activity of KP-103 against Malassezia furfur, showing that KP-103 was the most active among all tested drugs. PMC90494

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02812771 Onychomycosis PHASE4 COMPLETED 2019-01-14 Valeant Site 01, Birmingham, A... More >>labama, 35201, United States|Valeant Site 04, Fountain Valley, California, 92708, United States|Valeant Site 03, Santa Rosa, California, 95403, United States|Valeant SIte 05, South Miami, Florida, 33143, United States|Valeant Site 09, New Orleans, Louisiana, 70130, United States|Valeant Site 08, Baltimore, Maryland, 21214, United States|Valeant Site 02, Forest Hills, New York, 11375, United States|Valeant Site 06, Philadelphia, Pennsylvania, 19107, United States|Valeant Site 07, McAllen, Texas, 78501, United States|Valeant Site 10, Santo Domingo, Dominican Republic Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.87mL

0.57mL

0.29mL

14.35mL

2.87mL

1.44mL

28.70mL

5.74mL

2.87mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories